Last A$0.12 AUD
Change Today 0.00 / 0.00%
Volume 1.3M
AHZ On Other Exchanges
As of 12:10 AM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

admedus ltd (AHZ) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/10/14 - A$0.19
52 Week Low
11/5/14 - A$0.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ADMEDUS LTD (AHZ)

Related News

No related news articles were found.

admedus ltd (AHZ) Related Businessweek News

No Related Businessweek News Found

admedus ltd (AHZ) Details

Admedus Limited, a diversified healthcare company, focuses on developing and commercializing next generation technologies. The company is involved in the process of commercializing its tissue engineering technology for regenerative medicine. It provides CardioCel, a cardiovascular scaffold for the repair and correction of congenital heart deformities, and repair of damaged tissue, including defective heart valves. The company is also developing the next generation vaccines that target diseases, such as herpes and human papillomavirus. In addition, it distributes disposable medical products and medical devices, as well as is involved in the bioimplants and DNA vaccines operations. The company was formerly known as Allied Healthcare Group Limited and changed its name to Admedus Limited in November 2013. Admedus Limited is based in Perth, Australia.

admedus ltd (AHZ) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: A$350.9K
Chief Financial Officer and Company Secretary
Total Annual Compensation: A$191.5K
Chief Operating Officer
Total Annual Compensation: A$315.3K
Executive Director
Total Annual Compensation: --
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

admedus ltd (AHZ) Key Developments

Admedus Limited Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 05:00 PM

Admedus Limited Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 05:00 PM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Admedus Limited - Shareholder/Analyst Call

Admedus Limited - Shareholder/Analyst Call

Admedus Limited Announces Board Appointments

Admedus Limited announced that it has appointed two new directors to its Board. Mr. John Seaberg and Mr. Wayne Paterson have been appointed as independent, non-executive directors. Mr. Seaberg brings with him 37 years' experience in the international medical devices industry with a strong background in development, sales and marketing. He has been involved in both national and multi-national medical device companies, particularly in the cardiovascular space. Mr. Paterson joins Admedus after 20 years as a senior executive in the international pharmaceutical industry, with extensive managerial and marketing experience to the emerging, European and US markets. From 2007 until May 2014, Mr. Seaberg was Founder, Chairman and CEO of NeoChord Inc. Currently, Mr. Seaberg manages the healthcare consulting practice at Platinum Group. Mr. Paterson has held numerous, senior positions in multi-national companies. Throughout his career, he has been responsible for building businesses throughout the world, as well as mergers and major restructures. From 2007 to 2013, Mr. Paterson held senior positions at Merck Serono. In his most recent position as President of Europe, Canada and Australia, he managed over $3 billion in sales with an operational budget of $500 million. Mr. Paterson also held the position of Global Head of Cardio Metabolic Care and General Medicine, with revenue responsibility of $1.5 billion, and was responsible for all aspects of company strategy, including manufacturing strategies, commercial operations and budgets.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AHZ:AU A$0.12 AUD 0.00

AHZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AHZ.
View Industry Companies

Industry Analysis


Industry Average

Valuation AHZ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.7x
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADMEDUS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at